Telomerase activity in bladder cancer, bladder washings and in urine

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1169-1173

  Müller, Markus ^a   Heine, Bernhard ^a   Heicappell, Rüdiger ^a   Emrich, Thomas ^b   Hummel, Michael ^a   Stein, Harald ^a   Miller, Kurt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

bladder cancer; bladder washings; non invasive detection; telomerase activity; urine

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; BLADDER CANCER; BLADDER IRRIGATION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; URINE;

EID: 0029803828     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1169     Document Type: Article

References (28)

1. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43: 405-413, 1985.
2. Morin GB: The human telomere terminal transfer as enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
3. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL and Wu JR: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988.
4. Blackburn EH: Structure and funktion of telomeres. Nature 350: 659-573, 1991.
5. Watson JD: Origins of concatemeric T7 DNA. Nat New Biol 239: 197-201, 1972.
6. Olovnikov AM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 41: 181-190, 1973.
7. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW and Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89: 10114-10118, 1992.
8. Feng J, Funk WD, Wang S, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang, E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
9. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright EW, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
10. Hiyama E, Hiyama K, Yokohama T, Matsuura Y, Piatyszek M and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1: 249-255, 1995.
11. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
12. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
13. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW and Toyama K: Telomerase reactivation in leukemia cells. Int J Oncol 8: 417-421, 1996.
14. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW and Coffey SC: Telomerase activity: a prevalent marker of malignant prostate tissue. Cancer Res 56: 218-222, 1996.
15. Chadeneau C, Hay K, Hirte HW, Gallinger S and Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
16. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y and Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 2: 929-932, 1996.
17. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
18. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
19. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW: Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 106: 759-765, 1996.
20. Wright WE, Shay JW and Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23: 3794-3795, 1995.
21. Ohyashiki JH, Ohyashiki K, Sano T and Toyama K: Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 87: 329-331, 1996.
22. Mollhof S and Rathert P: What is the value of urine cytology in after-care of patients with urothelial cancers. Urology A 31: 203-205, 1992.
23. Wawroschek F and Rathert P: Urine cytology. Urology A 34: 69-75, 1995.
24. Brendler CB: Flow cytometric evaluation of urological malignancy. J Urol 139: 342-343, 1988.
25. Koss LG: Cytology - accuracy of diagnosis. Cancer 64 (Suppl): 249-252, 1989.
26. Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossmann GM, Hodges GM, Messing EM and Schmitz-Draeger BJ: Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. J Urol 146: 1631-1636, 1991.
27. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
28. Bryan T, Englezou A, Gupta J, Bacchetti S and Reddel R: Telomerc elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248, 1995.